UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 533

Sortiert nach

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

Annals of oncology, 2017-02, Vol.28 (2), p.368-376

2017

Volltextzugriff (PDF)

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

Journal of clinical oncology, 2001-05, Vol.19 (9), p.2370-2380

2001

Volltextzugriff (PDF)

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells

Oncogene, 2016-03, Vol.35 (10), p.1225-1235

2016

Volltextzugriff (PDF)

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2015-11, Vol.373 (19), p.1803-1813

2015

Volltextzugriff (PDF)

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

Circulation (New York, N.Y.), 2001-07, Vol.104 (3), p.257-262

2001

Volltextzugriff (PDF)

LB1019 Successful treatment of in-transit metastatic melanoma with intralesional TVEC and topical imiquimod

Journal of investigative dermatology, 2024-08, Vol.144 (8), p.S180-S180

2024

Volltextzugriff (PDF)

Melanoma from bench to bedside: meeting report from the 6th international melanoma congress

Pigment cell & melanoma research, 2010-02, Vol.23 (1), p.14-26

2010

Volltextzugriff (PDF)

Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment

Journal of acquired immune deficiency syndromes (1999), 2000-04, Vol.23 (5), p.396

2000

Volltextzugriff (PDF)

Cost and Threshold Analysis of an HIV/STI/Hepatitis Prevention Intervention for Young Men Leaving Prison: Project START

AIDS and behavior, 2013-10, Vol.17 (8), p.2676-2684

2013

Volltextzugriff (PDF)

Séquençage de mélanomes via capture par hybridation : identification d’altérations BRAF dans des prélèvements auparavant considérés comme non-mutés

Annales de dermatologie et de vénéréologie, 2017-12, Vol.144 (12), p.S90-S91

2017

Volltextzugriff (PDF)

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

Journal of cancer research and clinical oncology, 2002-04, Vol.128 (4), p.214-218

2002

Volltextzugriff (PDF)

Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production

Blood, 1997-10, Vol.90 (7), p.2541

1997

Volltextzugriff (PDF)

23 Clinical Status of RAF/MEK Inhibitors

European journal of cancer (1990), 2012-11, Vol.48, p.10-10

2012

Volltextzugriff (PDF)

Sunlight and Reduced Risk of Cancer: Is The Real Story Vitamin D?

JNCI : Journal of the National Cancer Institute, 2005-02, Vol.97 (3), p.161-163

2005

Volltextzugriff (PDF)

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

The New England journal of medicine, 2007-05, Vol.356 (22), p.2271-2281

2007

Volltextzugriff (PDF)

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

The New England journal of medicine, 2012-09, Vol.367 (13), p.1187-1197

2012

Volltextzugriff (PDF)

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

Clinical cancer research, 2000-09, Vol.6 (9), p.3442-3450

2000

Volltextzugriff (PDF)

Outpatient Biochemotherapy With Interleukin-2 and Interferon Alfa-2b in Patients With Metastatic Malignant Melanoma: Results of Two Phase II Cytokine Working Group Trials

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3194-3202

2001

Volltextzugriff (PDF)

Stereotactic Radiosurgery Plus Whole Brain Radiation Therapy vs. Stereotactic Radiosurgery Alone in the Treatment of Brain Metastases from Malignant Melanoma

International journal of radiation oncology, biology, physics, 2010, Vol.78 (3), p.S262-S263

2010

Volltextzugriff (PDF)

Predictors of risky sex of young men after release from prison

International journal of STD & AIDS, 2003-08, Vol.14 (8), p.519

2003

Volltextzugriff (PDF)

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025

European urology, 2017-09, Vol.72 (3), p.368-376

2017

Volltextzugriff (PDF)

Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability

International journal of STD & AIDS, 2005-02, Vol.16 (2), p.117

2005

Volltextzugriff (PDF)

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease

Bone marrow transplantation (Basingstoke), 2000-08, Vol.26 (4), p.445-449

2000

Volltextzugriff (PDF)

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study

Journal of clinical oncology, 1998-02, Vol.16 (2), p.664-669

1998

Volltextzugriff (PDF)

Pilot Trial of Interleukin-2 With Granulocyte Colony-Stimulating Factor for the Mobilization of Progenitor Cells in Advanced Breast Cancer Patients Undergoing High-Dose Chemotherapy: Expansion of Immune Effectors Within the Stem-Cell Graft and Post–Stem-Cell Infusion

Journal of clinical oncology, 2001-02, Vol.19 (3), p.634-644

2001

Volltextzugriff (PDF)

1 – 25 von 533

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(490)
Mit Volltextzugriff
(443)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab

High-Dose Interferon Alfa-2b Significantly Prolongs Relapse-Free and Overall Survival Compared With the GM2-KLH/QS-21 Vaccine in Patients With Resected Stage IIB-III Melanoma: Results of Intergroup Trial E1694/S9512/C509801

Fibronectin induction abrogates the BRAF inhibitor response of BRAF V600E/PTEN-null melanoma cells

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction

LB1019 Successful treatment of in-transit metastatic melanoma with intralesional TVEC and topical imiquimod

Melanoma from bench to bedside: meeting report from the 6th international melanoma congress

Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment

Cost and Threshold Analysis of an HIV/STI/Hepatitis Prevention Intervention for Young Men Leaving Prison: Project START

Séquençage de mélanomes via capture par hybridation : identification d’altérations BRAF dans des prélèvements auparavant considérés comme non-mutés

Temozolomide and whole brain irradiation in melanoma metastatic to the brain: a phase II trial of the Cytokine Working Group

Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production

23 Clinical Status of RAF/MEK Inhibitors

Sunlight and Reduced Risk of Cancer: Is The Real Story Vitamin D?

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy

Phase II Trial of Interleukin 2, Interferon α, and 5-Fluorouracil in Metastatic Renal Cell Cancer: A Cytokine Working Group Study

Outpatient Biochemotherapy With Interleukin-2 and Interferon Alfa-2b in Patients With Metastatic Malignant Melanoma: Results of Two Phase II Cytokine Working Group Trials

Stereotactic Radiosurgery Plus Whole Brain Radiation Therapy vs. Stereotactic Radiosurgery Alone in the Treatment of Brain Metastases from Malignant Melanoma

Predictors of risky sex of young men after release from prison

Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025

Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability

Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease

Phase II study of carmustine, dacarbazine, cisplatin, and tamoxifen in advanced melanoma: a Southwest Oncology Group study

Pilot Trial of Interleukin-2 With Granulocyte Colony-Stimulating Factor for the Mobilization of Progenitor Cells in Advanced Breast Cancer Patients Undergoing High-Dose Chemotherapy: Expansion of Immune Effectors Within the Stem-Cell Graft and Post–Stem-Cell Infusion

Suchergebnisse filtern